Diagnosis, aetiopathogenesis and treatment of fibromyalgia :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Fibromyalgia: An Update on Diagnosis, Aetiopathogenesis and Treatment

Fibromyalgia Fibromyalgia
Fibromyalgia Fibromyalgia

Fibromyalgia, a complex multidimensional pain disease, affects 2–8% of the general population. It is categorized as "chronic primary pain" by World Health Organization Eleventh Revision of International Classification of Diseases (WHO ICD-11).

See All

Attachment
Previous

Next
Safety and efficacy of anti-CGRP monoclonal antibodies for resistant chronic migraine

Comments (0)

Recommendations

Read
Watch

Read about which strategies may boost vaccination rates

Cannabinoids show promise in improving quality of life for IBD pa...

Tenoxicam: A Powerful Solution for Pain and Inflammatory Conditio...

Dysmenorrhea affects quality of life in over 70% of women, study...

Efficacy and safety of nonsteroidal anti-inflammatory drugs in As...

An introduction to pain pathways and mechanisms

Thank you for your participation!

Association between pain, central sensitization and anxiety in po...

Related Content

Fibromyalgia: An Update on Diagnosis, Aetiopathogenesis and Treat...

Related Tags

xx

Next

378
Summaries

Safety and efficacy of anti-CGRP monoclonal antibodies for resist...

To evaluate the efficacy and safety of anti-calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAb) in patients with refractory chroni...

3 min More details
You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try:

This website uses cookies to help us give you the best experience when you visit.

By using this website you consent to our use of cookies. For more information please review our cookie policy.